Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elise Lepoix"'
Publikováno v:
European Journal of Clinical Pharmacology. 78:687-690
Pembrolizumab is a humanized monoclonal antibody that binds to the programmed cell-death protein-1 (PD-1) on immune T-cells, thus blocking PD-1 activity. Pembrolizumab is indicated for the treatment of advanced melanoma, metastatic non-small-cell lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ada3dbbf9ba194a0054c2abbc5df78
https://doi.org/10.1007/s00228-021-03273-z
https://doi.org/10.1007/s00228-021-03273-z
Autor:
Elise Lepoix, Camille Mazza, Florian Slimano, Damien Botsen, Anne Grange, Olivier Bouché, Mathilde Brasseur
Publikováno v:
Supportive Care in Cancer. 27:3179-3182
This study was undertaken to assess the previously unevaluated safety and feasibility of oxaliplatin-desensitization procedure add a French ambulatory cancer unit, which is a current topic in oncology. Our findings demonstrated that oxaliplatin-desen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2b18c50d7cfab4531530d6741b8313
https://doi.org/10.1007/s00520-019-04863-5
https://doi.org/10.1007/s00520-019-04863-5
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.04.017⟩
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.04.017⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee30719c791283fda7a60331d2c45c31
https://hal.archives-ouvertes.fr/hal-03474589
https://hal.archives-ouvertes.fr/hal-03474589
